Abstract
We describe the use of transcatheter aortic valve replacement to allow for bridging to a left ventricular assist device in a patient with end-stage heart failure, secondary to nonischemic cardiomyopathy and severe bioprosthetic aortic valve regurgitation.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
MeSH terms
-
Aortic Valve Insufficiency / surgery*
-
Bioprosthesis
-
Follow-Up Studies
-
Heart Failure, Systolic / diagnosis
-
Heart Failure, Systolic / surgery*
-
Heart-Assist Devices*
-
Hemodynamics
-
Humans
-
Male
-
Middle Aged
-
Minimally Invasive Surgical Procedures / methods
-
Prosthesis Failure
-
Risk Assessment
-
Severity of Illness Index
-
Shock, Cardiogenic / surgery
-
Stroke Volume
-
Transcatheter Aortic Valve Replacement / methods*
-
Treatment Outcome